SESSION TITLE: Pharmacogenomics to Pharmaco-omics of Major Depression and SSRI Response
BIOGRAPHY: Dr. Weinshilboum received B.A. and M.D. degrees from the University of Kansas, followed by residency training in Internal Medicine at the Massachusetts General Hospital in Boston, a Harvard teaching hospital. He was also a Pharmacology Research Associate at the NIH in the laboratory of Nobel Laureate Dr. Julius Axelrod. He is presently Professor of Pharmacology and Medicine and Dasburg Professor of Cancer Genomics Research at the Mayo Clinic and he co-directs the Pharmacogenomics Program of the Mayo Center for Individualized Medicine with his faculty colleague, Dr. Liewei Wang, MD-PhD. Dr. Weinshilboum’s research has focused on pharmacogenomics, with over 460 peer-reviewed manuscripts and an emphasis in recent decades on the application of genome-wide genomics and other “omics” techniques to study variation in drug response–especially the drug therapy of depression. He has served on the National Advisory Councils for two NIH Institutes, the National Institute for General Medical Sciences and the National Human Genome Research Institute.